Neuralink's Blindsight chip, set for human trials in 2025, aims to restore vision for the blind by directly stimulating the brain's visual cortex.

Elon Musk's brain-chip company Neuralink is set to implant its revolutionary Blindsight chip on its first human patient in 2025. The test chip, approved by the ...

Elon Musk has said that the first person to receive the Blindsight version of Neuralink will be treated this year.

Neuralink’s Blindsight implant aims to restore vision for the blind using a brain-computer interface, with future potential for superhuman sight beyond human capabilities.

Elon Musks Neuralink is set to revolutionize vision restoration with its groundbreaking Blindsight technology, aimed at giving sight back to the blind. With human trials starting by 2025, this ...

Elon Musk's startup, Neuralink, plans to implant its artificial visual prosthesis, 'Blindsight', in a human for the first time by late 2025.

Elon Musk’s brain chip company, Neuralink, is aiming to achieve a major medical milestone by the end of 2025 with the first human implantation of its artificial visual prosthesis, Blindsight.

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.